Key Sessions
Stefanos Grammatikos
KEYNOTE ADDRESS – Bioprocess Innovations in the Era of Acceleration and Intensification
UCB Pharma
Stefanos Grammatikos
KEYNOTE ADDRESS – Bioprocess Innovations in the Era of Acceleration and Intensification
UCB Pharma
keyboard_arrow_right
Search & Filter keyboard_arrow_right
keyboard_arrow_left Hide
MAIN CONFERENCE DAY THREE - PST/PDT (Pacific Daylight, GMT-7)
keyboard_arrow_leftSearch & Filter
search
Streams
Formats
MAIN CONFERENCE DAY THREE - PST/PDT (Pacific Daylight, GMT-7)
search
Streams
Formats
7:15am - 8:05am50 mins
Continental Breakfast
8:05am - 8:10am5 mins
Track 1: Cell Line Development & Engineering
Chairperson's Opening Remarks
8:05am - 8:10am5 mins
Track 2: Cell Culture & Upstream Processing
Chairperson’s Opening Remarks
8:05am - 8:10am5 mins
Track 3: Recovery & Purification
Chairperson’s Opening Remarks
8:05am - 8:10am5 mins
Track 4: BioProcessing 4.0
Chairperson’s Opening Remarks
8:05am - 8:10am5 mins
Track 5: Intensified & Continuous Processing
Chairperson’s Opening Remarks
8:10am - 8:40am30 mins
Track 1: Cell Line Development & Engineering
KEYNOTE ADDRESS - The Transition from Protein-Based to Cell and Gene Therapy Products – Advantages, Surprises and Lessons Learned
- Uwe Gottschalk, Ph.D. - Chief Scientific Officer, Lonza
8:10am - 8:40am30 mins
Track 2: Cell Culture & Upstream Processing
KEYNOTE ADDRESS - The Transition from Protein-Based to Cell and Gene Therapy Products – Advantages, Surprises and Lessons Learned
- Uwe Gottschalk, Ph.D. - Chief Scientific Officer, Lonza
8:10am - 8:40am30 mins
Track 3: Recovery & Purification
KEYNOTE ADDRESS - The Transition from Protein-Based to Cell and Gene Therapy Products – Advantages, Surprises and Lessons Learned
- Uwe Gottschalk, Ph.D. - Chief Scientific Officer, Lonza
8:10am - 8:40am30 mins
Track 4: BioProcessing 4.0
KEYNOTE ADDRESS - The Transition from Protein-Based to Cell and Gene Therapy Products – Advantages, Surprises and Lessons Learned
- Uwe Gottschalk, Ph.D. - Chief Scientific Officer, Lonza
8:10am - 8:40am30 mins
Track 5: Intensified & Continuous Processing
KEYNOTE ADDRESS - The Transition from Protein-Based to Cell and Gene Therapy Products – Advantages, Surprises and Lessons Learned
- Uwe Gottschalk, Ph.D. - Chief Scientific Officer, Lonza
8:40am - 9:10am30 mins
Track 1: Cell Line Development & Engineering
Establishment of Efficient Platforms for The Generation of Cell Lines Expressing Bispecific Proteins with Desired Quality Attributes
- Jie Zhu, Ph.D. - Associate Director, Cell Culture and Fermentation Sciences, BioPharmaceuticals, AstraZeneca
8:40am - 9:10am30 mins
Track 2: Cell Culture & Upstream Processing
KEYNOTE ADDRESS – Genentech’s Evolve Initiative
- Josefine Persson, Ph.D. - Associate Director, Purification Development, Genentech
8:40am - 9:10am30 mins
Track 3: Recovery & Purification
KEYNOTE ADDRESS – Genentech’s Evolve Initiative
- Josefine Persson, Ph.D. - Associate Director, Purification Development, Genentech
8:40am - 9:10am30 mins
Track 4: BioProcessing 4.0
KEYNOTE ADDRESS – Genentech’s Evolve Initiative
- Josefine Persson, Ph.D. - Associate Director, Purification Development, Genentech
8:40am - 9:10am30 mins
Track 5: Intensified & Continuous Processing
KEYNOTE ADDRESS – Genentech’s Evolve Initiative
- Josefine Persson, Ph.D. - Associate Director, Purification Development, Genentech
9:10am - 9:15am5 mins
Track 1: Cell Line Development & Engineering
Transition to the Technology Workshops
9:10am - 9:15am5 mins
Track 2: Cell Culture & Upstream Processing
Transition to the Technology Workshops
9:10am - 9:15am5 mins
Track 3: Recovery & Purification
Transition to the Technology Workshops
9:10am - 9:15am5 mins
Track 4: BioProcessing 4.0
Transition to the Technology Workshops
9:10am - 9:15am5 mins
Track 5: Intensified & Continuous Processing
Transition to the Technology Workshops
9:15am - 9:45am30 mins
Track 1: Cell Line Development & Engineering
Innovation, Collaboration, and Technology Development - Leveraging the ThermoFisher Ecosystem to Accelerate Platform Improvements in Biopharmaceutical Manufacturing
- Frank Ritacco, PhD - Director, Scientific and Technical Affairs, Thermo Fisher Scientific, Pharma Services
9:15am - 9:45am30 mins
Track 2: Cell Culture & Upstream Processing
QX ONE Droplet Digital PCR for Cell Line Development
- Brandon McKethan, PhD - Field Application Specialist, Bio-Rad Laboratories, Inc.
9:15am - 9:45am30 mins
Track 3: Recovery & Purification
Technology Workshop 3
9:15am - 9:45am30 mins
Track 4: BioProcessing 4.0
Technology Workshop 4
9:15am - 9:45am30 mins
Track 5: Intensified & Continuous Processing
Technology Workshop 5
9:45am - 10:25am40 mins
Track 1: Cell Line Development & Engineering
Refreshment Break in the Exhibit & Poster Hall
9:45am - 10:25am40 mins
Track 2: Cell Culture & Upstream Processing
Refreshment Break in the Exhibit & Poster Hall
9:45am - 10:25am40 mins
Track 3: Recovery & Purification
Refreshment Break in the Exhibit & Poster Hall
9:45am - 10:25am40 mins
Track 4: BioProcessing 4.0
Refreshment Break in the Exhibit & Poster Hall
9:45am - 10:25am40 mins
Track 5: Intensified & Continuous Processing
Refreshment Break in the Exhibit & Poster Hall
9:45am - 9:55am10 mins
Live Theater Schedule
CMC Study of Viral Vector in CAR-T
- Sasidhar Murikinati - Regional Marketing Manager, GenScript ProBio
10:00am - 12:00pm120 mins
Track 7: Emerging & Innovative Technologies
Emerging & Innovative Technologies
- Cheryl Huie - Co-Executive Director, BioInnovation Group
- Lynne Frick - CEO, 4th Dimension Bioprocess, Inc.
- Yan Chen - Innovation Leader, Technical Development Principal Scientist, Genentech
- Judy Hsii - Senior Director, Downstream Processing, Sutro Biopharma
10:00am - 11:30am90 mins
Live Theater Schedule
BioInnovation Panel
- Lynne Frick - CEO, 4th Dimension Bioprocess, Inc.
- Jean Bender - Vice President, Visterra, Inc.
- Yan Chen - Innovation Leader, Technical Development Principal Scientist, Genentech
- Judy Hsii - Senior Director, Downstream Processing, Sutro Biopharma
10:25am - 10:30am5 mins
Track 1: Cell Line Development & Engineering
Chairperson's Remarks
10:25am - 10:30am5 mins
Track 2: Cell Culture & Upstream Processing
Chairperson's Remarks
10:25am - 10:30am5 mins
Track 3: Recovery & Purification
Chairperson's Remarks
10:25am - 10:30am5 mins
Track 4: BioProcessing 4.0
Chairperson's Remarks
- Moritz von Stosch - Senior Manager, Process Systems Biology and Engineering Center of Excellence, Technical R&D, GlaxoSmithKline
10:25am - 10:30am5 mins
Track 5: Intensified & Continuous Processing
Chairperson's Remarks
10:25am - 10:30am5 mins
Track 6: Gene Therapy Development & Production
Chairperson's Remarks
10:30am - 11:00am30 mins
Track 1: Cell Line Development & Engineering
Using Site Specific Integration Expression System to Generate Cell Lines for Multi-specific Modalities
- Barbara Tevelev - Senior Scientist, Molecular Discovery, Cell Line Development, Bioprocess Research and Development, Pfizer
10:30am - 11:00am30 mins
Track 2: Cell Culture & Upstream Processing
KEYNOTE ADDRESS – Bioprocess Innovations in the Era of Acceleration and Intensification
- Stefanos Grammatikos - VP - Head of Biotech Sciences, UCB Pharma
10:30am - 11:00am30 mins
Track 3: Recovery & Purification
KEYNOTE ADDRESS – Bioprocess Innovations in the Era of Acceleration and Intensification
- Stefanos Grammatikos - VP - Head of Biotech Sciences, UCB Pharma
10:30am - 11:00am30 mins
Track 4: BioProcessing 4.0
TELECONFERENCE: Paving the Way for Real time Product Quality Attribute Monitoring in Biologics Development
- Dhanuka Wasalathanthri - Senior Scientist, Bristol Myers Squibb
10:30am - 11:00am30 mins
Track 5: Intensified & Continuous Processing
KEYNOTE ADDRESS – Bioprocess Innovations in the Era of Acceleration and Intensification
- Stefanos Grammatikos - VP - Head of Biotech Sciences, UCB Pharma
10:30am - 11:00am30 mins
Track 6: Gene Therapy Development & Production
KEYNOTE ADDRESS: Gene Therapy: Hopes and Challenges
- Shawn Liu, PhD - Chief Scientist & Department Head, Bayer Healthcare LLC
11:00am - 11:30am30 mins
Track 1: Cell Line Development & Engineering
Advantages of Yeast-based Production, Genome-Engineering Technologies In Yeast That May Translate to Human Cell Lines.
- Bob St. Onge - Research Scientist, Stanford University
11:00am - 11:30am30 mins
Track 2: Cell Culture & Upstream Processing
Process Intensification: Implementation of Continuous Manufacturing in Upstream Processing
- William Napoli - Scientist, Sanofi
11:00am - 11:30am30 mins
Track 3: Recovery & Purification
Process Intensification: Implementation of Continuous Manufacturing in Upstream Processing
- William Napoli - Scientist, Sanofi
11:00am - 11:30am30 mins
Track 4: BioProcessing 4.0
Integrated Process Modelling: A Companion from Process Development to Control Strategy
- Christopher Taylor - Head of Consulting, Exputec
11:00am - 11:30am30 mins
Track 5: Intensified & Continuous Processing
Process Intensification: Implementation of Continuous Manufacturing in Upstream Processing
- William Napoli - Scientist, Sanofi
11:00am - 11:30am30 mins
Track 6: Gene Therapy Development & Production
Innovations in Vector Technologies
- Guangping Gao, Ph.D. - Professor, Gene Therapy Center, University of Massachusetts Medical School
11:30am - 12:00pm30 mins
Track 1: Cell Line Development & Engineering
Full-to-empty ratio of AAV on LabChip® GXII Touch™ Platform
- Natalia Rodionova, Ph.D. - Senior Application Scientist, PerkinElmer
11:30am - 12:00pm30 mins
Track 2: Cell Culture & Upstream Processing
VAYU Sense Intelligent Controller- A Revolutionary Closed Loop Solution for Fermentation Optimization
- Dalit Weinstein-Fischer - CTO, VAYU Sense
11:30am - 12:00pm30 mins
Track 3: Recovery & Purification
VAYU Sense Intelligent Controller- A Revolutionary Closed Loop Solution for Fermentation Optimization
- Dalit Weinstein-Fischer - CTO, VAYU Sense
11:30am - 12:00pm30 mins
Track 4: BioProcessing 4.0
Scientific Track Presentation
11:30am - 12:00pm30 mins
Track 5: Intensified & Continuous Processing
Scientific Track Presentation
11:30am - 12:00pm30 mins
Track 6: Gene Therapy Development & Production
Hemophilia A Ameliorated in Mice by CRISPR-based In Vivo Genome Editing of Human Factor VIII
- Oscar Segurado, MD, PhD - Chief Medical Officer, ASC Therapeutics Inc.
12:00pm - 1:25pm85 mins
Track 1: Cell Line Development & Engineering
Networking Luncheon in the Exhibit & Poster Hall
12:00pm - 1:25pm85 mins
Track 2: Cell Culture & Upstream Processing
Networking Luncheon in the Exhibit & Poster Hall
12:00pm - 1:25pm85 mins
Track 3: Recovery & Purification
Networking Luncheon in the Exhibit & Poster Hall
12:00pm - 1:25pm85 mins
Track 4: BioProcessing 4.0
Networking Luncheon in the Exhibit & Poster Hall
12:00pm - 1:25pm85 mins
Track 5: Intensified & Continuous Processing
Networking Luncheon in the Exhibit & Poster Hall
12:00pm - 1:25pm85 mins
Track 6: Gene Therapy Development & Production
Networking Luncheon in the Exhibit & Poster Hall
12:00pm - 1:25pm85 mins
Track 7: Emerging & Innovative Technologies
Networking Luncheon in the Exhibit & Poster Hall
12:10pm - 12:20pm10 mins
Live Theater Schedule
Culpeo QCL-IR Analyzer for Online Monitoring of Bioreactor Growth Media and Waste Products
- Jeremy Rowlette - Sr. Director | Scientific and Life Sciences Product Line, DRS Daylight Solutions
12:20pm - 12:40pm20 mins
Live Theater Schedule
Rapid Development of Scalable Biomanufacturing Solutions for Complex Biologics in E. coli SoluPro®
- Melissa Patterson - Director, Alliance Management, AbSci
12:40pm - 12:50pm10 mins
Live Theater Schedule
Biologics IND application: CMC platform by GenScript
- Sasidhar Murikinati - Regional Marketing Manager, GenScript ProBio
12:50pm - 1:10pm20 mins
Live Theater Schedule
Bypass E. coli transformation using the fully automated BioXp™ 3200 System for production of transfection ready DNA, libraries, and complex Gibson Assemblies
- Bonnie Kim - Business Development Manager, SGI-DNA
1:25pm - 1:30pm5 mins
Track 1: Cell Line Development & Engineering
Chairperson's Remarks
1:25pm - 1:30pm5 mins
Track 2: Cell Culture & Upstream Processing
Chairperson’s Remarks
1:25pm - 1:30pm5 mins
Track 3: Recovery & Purification
Chairperson’s Remarks
1:25pm - 1:30pm5 mins
Track 4: Bioprocessing 4.0
Chairperson's Remarks
1:25pm - 1:30pm5 mins
Track 5: Intensified & Continuous Processing
Chairperson’s Remarks
1:25pm - 1:30pm5 mins
Track 6: Gene Therapy Development & Production
Chairperson's Remarks
1:30pm - 2:00pm30 mins
Track 2: Cell Culture & Upstream Processing
Cell Culture Process Intensification: A Combined Lab-Scale, Modeling and Engineering Approach
- Helmut Brod, Ph.D. - Director Upstream Technologies, Bayer AG
1:30pm - 2:00pm30 mins
Track 3: Recovery & Purification
Cell Culture Process Intensification: A Combined Lab-Scale, Modeling and Engineering Approach
- Helmut Brod, Ph.D. - Director Upstream Technologies, Bayer AG
1:30pm - 2:00pm30 mins
Track 4: Bioprocessing 4.0
Hybrid Modeling and Intensified DOE Enabling Faster Process Understanding and Model Predictive Control
- Benjamin Bayer, Msc - Data Scientist at Novasign and PhD student at the Department of Biotechnology, Novasign/ University of Natural Resources and Life Sciences
1:30pm - 2:00pm30 mins
Track 5: Intensified & Continuous Processing
Cell Culture Process Intensification: A Combined Lab-Scale, Modeling and Engineering Approach
- Helmut Brod, Ph.D. - Director Upstream Technologies, Bayer AG
1:30pm - 2:00pm30 mins
Track 6: Gene Therapy Development & Production
The Winning Path to Gene Therapy: High Titer and Activity AAV Production Technology Development and Implementation
- Haifeng Chen, PhD - Chief Scientific Officer, Avirmax, Inc.
2:00pm - 2:30pm30 mins
Track 2: Cell Culture & Upstream Processing
Process Intensification Via Adaptive Continuous Variable Feeds with a Low Perfusion Rate
- Jeong Lee, Ph.D. - Principal Scientist, Cell Culture and Fermentation Sciences, AstraZeneca
2:00pm - 2:30pm30 mins
Track 3: Recovery & Purification
Process Intensification Via Adaptive Continuous Variable Feeds with a Low Perfusion Rate
- Jeong Lee, Ph.D. - Principal Scientist, Cell Culture and Fermentation Sciences, AstraZeneca
2:00pm - 2:30pm30 mins
Track 5: Intensified & Continuous Processing
Process Intensification Via Adaptive Continuous Variable Feeds with a Low Perfusion Rate
- Jeong Lee, Ph.D. - Principal Scientist, Cell Culture and Fermentation Sciences, AstraZeneca
2:00pm - 2:30pm30 mins
Track 6: Gene Therapy Development & Production
Overcoming Gene Therapy Manufacturing Scale Up bottlenecks – Technologies and Progress
- Jeffrey Hung - Chief Technology Officer, Vigene Biosciences, Inc.
2:30pm - 3:00pm30 mins
Track 2: Cell Culture & Upstream Processing
Topic and Presenter TBD
2:30pm - 3:00pm30 mins
Track 3: Recovery & Purification
Topic and Presenter TBD
2:30pm - 3:00pm30 mins
Track 5: Intensified & Continuous Processing
Topic and Presenter TBD
2:30pm - 3:00pm30 mins
Track 6: Gene Therapy Development & Production
Key Considerations in Formulation and Drug Product Development for Gene Therapy
- Rafi Mohammad, PhD - Staff Development Scientist, Bayer U.S. LLC
3:00pm - 3:15pm15 mins
Conference Recep, Closing Remarks and Look Ahead to BPI WEST 2021
Get the latest news.
As it happens
Sign up to get the latest on the agenda and speakers.
Filter
Streams
Formats